Vir Biotechnology SG&A Expense (Quarterly) Analysis

Vir Biotechnology Inc (VIR)

9.72 -0.21 (-2.11%) USD | NASDAQ | May 17, 16:00

9.72 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	36.27M
December 31, 2023	43.09M
September 30, 2023	41.08M
June 30, 2023	47.10M
March 31, 2023	46.78M
December 31, 2022	38.74M
September 30, 2022	43.17M
June 30, 2022	41.59M
March 31, 2022	38.26M
December 31, 2021	55.78M
September 30, 2021	50.50M
June 30, 2021	28.78M

Date	Value
March 31, 2021	25.74M
December 31, 2020	23.04M
September 30, 2020	18.86M
June 30, 2020	16.39M
March 31, 2020	12.65M
December 31, 2019	11.81M
September 30, 2019	9.22M
June 30, 2019	8.011M
March 31, 2019	8.559M
December 31, 2018	7.949M
September 30, 2018	7.394M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

8.011M

Minimum

Jun 2019

55.78M

Maximum

Dec 2021

31.84M

Average

37.26M

Median

SG&A Expense (Quarterly) Benchmarks